Search research articles
Contact Us
Filters
Showing results (771-780 of 782) with videos related to
Page
of 79
Sort By:
Annals of Surgery
|
October 26, 2017
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
Paula Ghaneh, Jorg Kleeff, Christopher M Halloran, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 24, 2024
Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel Disease
Joi F McLaughlin, Tiffany Linville, Traci W Jester, et al.
Journal of Neurotrauma
|
December 10, 2015
Early Decompression following Cervical Spinal Cord Injury: Examining the Process of Care from Accident Scene to Surgery
Camila R Battistuzzo, Alex Armstrong, Jillian Clark, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 13, 2025
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy
Doreen Zhu, Parminder K Judge, Susan T Francis, et al.
Journal of the National Cancer Institute
|
December 5, 2013
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial
William Greenhalf, Paula Ghaneh, John P Neoptolemos, et al.
Annals of the Rheumatic Diseases
|
December 6, 2014
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Journal of Medicinal Chemistry
|
January 24, 2012
Identification and preliminary characterization of a potent, safe, and orally efficacious inhibitor of acyl-CoA:diacylglycerol acyltransferase 1
Vince S C Yeh, David W A Beno, Sevan Brodjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models
Cherrie K Donawho, Yan Luo, Yanping Luo, et al.
The Lancet. Diabetes & Endocrinology
|
August 22, 2020
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial
Lakshminarayan R Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux, et al.
Human Mutation
|
July 31, 2010
Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations
Jennifer J Johnston, Julie C Sapp, Joyce T Turner, et al.
Page
of 79
Search research articles
Search
Showing results (771-780 of 782) with videos related to
Sort By:
Page
of 79
Annals of Surgery
|
October 26, 2017
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
Paula Ghaneh, Jorg Kleeff, Christopher M Halloran, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 24, 2024
Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel Disease
Joi F McLaughlin, Tiffany Linville, Traci W Jester, et al.
Journal of Neurotrauma
|
December 10, 2015
Early Decompression following Cervical Spinal Cord Injury: Examining the Process of Care from Accident Scene to Surgery
Camila R Battistuzzo, Alex Armstrong, Jillian Clark, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 13, 2025
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy
Doreen Zhu, Parminder K Judge, Susan T Francis, et al.
Journal of the National Cancer Institute
|
December 5, 2013
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial
William Greenhalf, Paula Ghaneh, John P Neoptolemos, et al.
Annals of the Rheumatic Diseases
|
December 6, 2014
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Journal of Medicinal Chemistry
|
January 24, 2012
Identification and preliminary characterization of a potent, safe, and orally efficacious inhibitor of acyl-CoA:diacylglycerol acyltransferase 1
Vince S C Yeh, David W A Beno, Sevan Brodjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models
Cherrie K Donawho, Yan Luo, Yanping Luo, et al.
The Lancet. Diabetes & Endocrinology
|
August 22, 2020
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial
Lakshminarayan R Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux, et al.
Human Mutation
|
July 31, 2010
Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations
Jennifer J Johnston, Julie C Sapp, Joyce T Turner, et al.
Page
of 79